Main Menu

Our Work

Amgen Inc. v. Sanofi Aventisub LLC and Regeneron Pharmaceuticals, Inc.

In Amgen v. Sanofi, supported professor Ernst Berndt of the Massachusetts Institute of Technology in his application of the four eBay factors after Sanofi's biologic Praluent was found to infringe on patents related to Amgen's biologic Repatha. Among other topics, Dr. Berndt discussed the importance of intellectual property rights in providing the necessary incentives to develop new biologic treatments. A decision on a permanent injunction is expected by the end of 2016.

Jump to Page